In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest
- PMID: 17194821
- PMCID: PMC1803125
- DOI: 10.1128/AAC.01539-06
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest
Abstract
We evaluated the activities of amphotericin B, itraconazole, voriconazole, caspofungin, and posaconazole against zygomycetes by CLSI M38-A, Etest and Sensititre. The most active drug was posaconazole, followed by amphotericin B and itraconazole. The correlation of the Etest and Sensititre with CLSI M38-A was moderate for posaconazole but poor for the others.
Similar articles
-
Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.J Clin Microbiol. 2018 Sep 25;56(10):e00780-18. doi: 10.1128/JCM.00780-18. Print 2018 Oct. J Clin Microbiol. 2018. PMID: 30093391 Free PMC article.
-
Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.Diagn Microbiol Infect Dis. 2006 Sep;56(1):53-5. doi: 10.1016/j.diagmicrobio.2006.03.004. Epub 2006 May 2. Diagn Microbiol Infect Dis. 2006. PMID: 16650953
-
Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.J Antimicrob Chemother. 2003 Sep;52(3):365-70. doi: 10.1093/jac/dkg384. Epub 2003 Aug 13. J Antimicrob Chemother. 2003. PMID: 12917236
-
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.Med Mycol. 2008 Sep;46(6):567-73. doi: 10.1080/13693780801975576. Med Mycol. 2008. PMID: 19180726
-
Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?J Fungi (Basel). 2024 Mar 14;10(3):214. doi: 10.3390/jof10030214. J Fungi (Basel). 2024. PMID: 38535222 Free PMC article. Review.
Cited by
-
Treatment options in emerging mold infections.Curr Infect Dis Rep. 2008 Nov;10(6):473-9. doi: 10.1007/s11908-008-0077-9. Curr Infect Dis Rep. 2008. PMID: 18945388
-
Mucormycosis.Infect Dis Clin North Am. 2021 Jun;35(2):435-452. doi: 10.1016/j.idc.2021.03.009. Infect Dis Clin North Am. 2021. PMID: 34016285 Free PMC article. Review.
-
Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B.Clin Drug Investig. 2013 Feb;33 Suppl 1:S5-14. doi: 10.1007/s40261-012-0023-3. Clin Drug Investig. 2013. PMID: 23381977 Review.
-
Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).Haematologica. 2013 Apr;98(4):492-504. doi: 10.3324/haematol.2012.065110. Epub 2012 Sep 14. Haematologica. 2013. PMID: 22983580 Free PMC article. Review.
-
Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole.J Clin Microbiol. 2009 Apr;47(4):1244-8. doi: 10.1128/JCM.02030-08. Epub 2009 Jan 26. J Clin Microbiol. 2009. PMID: 19171681 Free PMC article.
References
-
- Berenguer, J., P. Munoz, F. Parras, V. Fernandez-Baca, T. Hernandez-Sampelayo, and E. Bouza. 1994. Treatment of deep mycoses with liposomal amphotericin B. Eur. J. Clin. Microbiol. Infect. Dis. 13:504-507. - PubMed
-
- Bouza, E., P. Munoz, and J. Guinea. 2006. Mucormycosis: an emerging disease? Clin. Microbiol. Infect. 12(Suppl. 7):7-23. - PubMed
-
- Brugiere, O., G. Dauriat, H. Mal, R. Marrash-Chalha, M. Fournier, O. Groussard, M. Besnard, G. Leseche, and B. Dupont. 2005. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy. Transplantation 80:1361-1362. - PubMed
-
- Reference deleted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical